Sava why this stock is considered undervalued?

Cassava Sciences (SAVA) is considered undervalued for several reasons:

1. High Growth Rates: Cassava Sciences has experienced a significant increase in net income, with a growth rate of 123.34% as of June 30, 2024. This indicates a strong financial performance and the potential for future growth.

2. Positive Analyst Ratings: The consensus rating for Cassava Sciences is a "Strong Buy" with an average price target of $74.33, which is significantly higher than the current trading price. This suggests that analysts are optimistic about the stock's future performance.
3. Institutional Confidence: Institutions have a significant stake in Cassava Sciences, with some owning as much as 29% of the company's stock. This implies that analysts working for these institutions have looked at the stock and believe in its potential.
4. Short Interest: The short percent of float for Cassava Sciences has risen, indicating an increase in short interest. This can sometimes signal that investors are bullish on the stock, as they expect the price to rise in the near term.
5. Options Market Sentiment: The options market shows a split between bearish and bullish sentiment, with a 38% bullish sentiment and 53% bearish sentiment among big-money traders. This suggests that there is no clear consensus on the stock's future direction, but the overall sentiment is slightly bullish.
6. Price Target: The average price target set by analysts is significantly higher than the current trading price, indicating that there is potential for the stock to appreciate in value.
7. P/E Ratio: Cassava Sciences has a negative P/E ratio of -26.56, which may seem concerning. However, this is due to recent allegations of data manipulation and potential fraud, which have led to a decline in the stock price. If these allegations are proven false or are resolved, the stock could rebound, making the current low P/E ratio an opportunity for investors.

In conclusion, Cassava Sciences is considered undervalued due to its high growth rates, positive analyst ratings, institutional confidence, short interest, and potential for appreciation in value. The negative P/E ratio is a result of allegations that may not be justified, providing a potential buying opportunity for investors.